C
Gilead Sciences, Inc. GILD
$83.05 -$0.11-0.13%
Recommendation
Hold
Prev Close
$83.16
Volume
7,078,516
Avg Vol (90D)
6,895,631
Market Cap
$103.53B
Dividend & Yield
$3.06(3.68%)
52-Week Range
$62.07 - $87.87
P/E (TTM)
103.29
EPS (TTM)
$0.8051
My Lists My Alerts
Report
Rating
Reward
B-
Good
Risk
D
Weak
Rating Factors
Growth Index
Fair
Efficiency Index
Good
Solvency Index
Excellent
Total Return Index
Fair
Volatility Index
Weak
Dividend Index
Good
Headlines
Gilead Sciences (GILD) Stock Sinks As Market Gains: Here's Why
9/17/2024 - Zacks Investment Research
December 20th Options Now Available For Gilead Sciences (GILD)
9/17/2024 - Stock Options Channel
Prime Capital Investment Advisors LLC Sells 9,233 Shares of Gilead Sciences, Inc. (NASDAQ:GILD)
9/17/2024 - Ticker Report
Gilead Sciences (NASDAQ:GILD) Receives Neutral Rating from Cantor Fitzgerald
9/17/2024 - Ticker Report
Gilead Sciences, Inc. (NASDAQ:GILD) Shares Sold by Envestnet Asset Management Inc.
9/16/2024 - Ticker Report
Buy Rating on Gilead Sciences: Underestimated Market Potential of Lenacapavir in HIV Treatment and Prevention
9/16/2024 - TipRanks Financial Blog
GHP Investment Advisors Inc. Has $727,000 Stock Holdings in Gilead Sciences, Inc. (NASDAQ:GILD)
9/15/2024 - Zolmax
GHP Investment Advisors Inc. Has $727,000 Position in Gilead Sciences, Inc. (NASDAQ:GILD)
9/15/2024 - Ticker Report
Quest Partners LLC Reduces Holdings in Gilead Sciences, Inc. (NASDAQ:GILD)
9/15/2024 - Zolmax
Gilead Sciences, Inc. (NASDAQ:GILD) Insider Sells $2,459,529.46 in Stock
9/15/2024 - Ticker Report
LPL Financial LLC Has $72.63 Million Stock Position in Gilead Sciences, Inc. (NASDAQ:GILD)
9/14/2024 - Zolmax
Got $200? 2 Healthcare Stocks to Buy and Hold Forever
9/14/2024 - Fool.com Headlines
Insider Sale: Johanna Mercier Sells 29,357 Shares of Gilead Sciences Inc (GILD)
9/14/2024 - GuruFocus
Gilead Stock Rises as HIV Prevention Injection Meets Study Goals
9/13/2024 - Zacks Investment Research
State of New Jersey Common Pension Fund D Has $31.31 Million Position in Gilead Sciences, Inc. (NASDAQ:GILD)
9/13/2024 - Ticker Report
State of New Jersey Common Pension Fund D Sells 252,647 Shares of Gilead Sciences, Inc. (NASDAQ:GILD)
9/13/2024 - Zolmax
Gilead Sciences (NASDAQ:GILD) Rating Reiterated by Piper Sandler
9/13/2024 - Zolmax
Gilead Sciences (NASDAQ:GILD) Rating Reiterated by Piper Sandler
9/13/2024 - Ticker Report
Buy Rating Affirmed for Gilead Sciences on Lenacapavir's Market-Changing Potential in PrEP
9/13/2024 - TipRanks Financial Blog
GILD: What's Driving Gilead Sciences Stock Up Today
9/12/2024 - GuruFocus
Why Gilead Sciences Stock Thrashed the Market Today
9/12/2024 - Yahoo! Finance: News
Why Gilead Sciences Stock Thrashed the Market Today
9/12/2024 - Fool.com Headlines
Gilead Sciences goes ex-dividend tomorrow
9/12/2024 - SeekingAlpha.com: All News
Gilead Unveils 'Remarkable Outcomes' From Late-Stage Lenacapavir Study Showing Promise In Preventing HIV Infections
9/12/2024 - Benzinga
Gilead Sciences' (NASDAQ:GILD) Latest Study Shows Further Effectiveness Against HIV
9/12/2024 - TipRanks Financial Blog
Income Statement
Total Revenue (TTM)
$27.80B
EBITDA (TTM)
$13.47B
EBIT (TTM)
$10.71B
Net Income (TTM)
$1.05B
Balance Sheet
Total Assets (Q)
$53.58B
Total Debt (Q)
$23.35B
Total Liabilities (Q)
$35.38B
Book Value Per Share (Q)
$14.67
Cash Flow
Cash from Operations (TTM)
$7.47B
Cash from Investing (TTM)
-$3.47B
Cash from Financing (TTM)
-$6.93B
Net Change in Cash (TTM)
-$2.93B
Filings
Filing Date
Thursday, August 8, 2024
Period Date
Sunday, June 30, 2024
Next Filing
Week of Nov 4 and 8 (est)
Price History
Loading...
Beta
0.48
7-Day Total Return
6.49%
30-Day Total Return
12.03%
60-Day Total Return
18.62%
90-Day Total Return
30.71%
Year to Date Total Return
2.98%
1-Year Total Return
14.39%
2-Year Total Return
36.39%
3-Year Total Return
31.33%
5-Year Total Return
54.09%
52-week Low
May 31, 2024 - $62.07
52-week High
Jan 19, 2024 - $87.87
Valuation
Market Cap
$103.53B - Large Cap
Enterprise Value
$123.02B
Price/Sales (TTM)
3.74
Price/Book (Q)
5.67
Dividends and Shares
Shares Outstanding
1.25B
Dividend Per Share (Most Recent)
$0.77
Dividend Per Share (TTM)
$3.06
Corporate Info
Website
www.gilead.com
Phone Number
650 574 3000
Address
333 Lakeside Drive
Foster City, CA 94404
Country
United States
Year Founded
1987
Business Description
Sector
Health Care
Industry
Pharmaceuticals, Biotechnology and Life Sciences
Gilead Sciences, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines in the areas of unmet medical need in the United States, Europe, and internationally. The... more
NASDAQ 09/17/2024 4:00PM Eastern Quotes delayed
Weiss Ratings